15 January 2021

KWM advises on Modern Chinese Medicine Group Co., Ltd.’s Hong Kong listing

King & Wood Mallesons (KWM) advised the sole sponsor and the underwriters on the HK$177 million global offering and initial public offering of Modern Chinese Medicine Group Co., Ltd. (Modern Chinese Medicine, SEHK Stock Code: 1643) on the Main Board of the Stock Exchange of Hong Kong Limited (SEHK).

Modern Chinese Medicine was listed on the SEHK on 15 January 2021. The listing was priced at HK$1.18 per share and comprised a total of 150,000,000 shares.

Modern Chinese Medicine is principally engaged in the production of proprietary Chinese medicine and offers both over the counter and prescribed medicines intended for the use by the middle-aged and the elderly in the PRC.

The team was led by partner Anthony Wan, with support from senior associate Albert Wong, associates Jason Choi and Annie Chau.


Media contact

Share on LinkedIn Share on Facebook Share on Twitter
    You might also be interested in

    King & Wood Mallesons (KWM) has won two awards at this year’s Asia Legal Awards, which was held virtually on 5 May.

    05 May 2021

    Our Hong Kong and Shanghai team advised on privatisation financings for Chinese companies listed overseas.

    28 April 2021

    We advised on CMB Financial Leasing’s financing to Viking Sun.

    26 April 2021

    We advised on MEGAIN's Hong Kong IPO.

    01 April 2021

    You may also be interested in...

    Legal services for your business

    This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

    For more information on which cookies we use then please refer to our Cookie Policy.